课题基金 / 基金详情

Understanding the Role of HAART in the Progression of HPV-Associated Oral Cancer

Understanding the Role of HAART in the Progression of HPV-Associated Oral Cancer
了解 HAART 在 HPV 相关口腔癌进展中的作用
批准号:
10528540
负责人:
Craig M Meyers
金额:
$55.58万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-11 至 2027-05-31

项目摘要

项目成果

Craig M Meyers的其他基金

相似基金

相关文献

中文摘要
翻译
总结 HPV+头颈部鳞状细胞癌(HNSCC)的总体发病率呈上升趋势, 过去几十年的趋势,现在在美国已经取代宫颈癌成为最常见的宫颈癌。 HPV相关癌症。大多数晚期HNSCC患者没有临床病史 癌前病变由于缺乏癌前临床样本, 我们已经开发了一种体外进展, 模型有趣的是,与HPV阴性(HPV-)患者相比,HPV+患者具有改善的总体免疫应答。 预后和更高的无病生存率,部分归因于对放疗和/或化疗的更好反应。 口腔HPV感染和致癌进展的机制和自然史知之甚少。 感染人类免疫缺陷病毒(HIV)的男性和女性HPV 16的发病率较高 感染、HPV 16持续时间较长、HNSCC发病率增加、预后较差,以及 更容易复发。癌症的负担发生了实质性变化 影响艾滋病毒感染者在美国的时期跨越引进高度活跃的抗- 逆转录病毒疗法(HAART)。HAART治疗的规模扩大大大增加了老年人的预期寿命。 艾滋病毒感染者(PLHIV)。由于这些时间上的变化,非艾滋病定义的癌症已经出现, 在高效抗逆转录病毒疗法时代,艾滋病毒感染者的癌症中,在这些新兴的 口腔/咽部的HPV相关癌症, 艾滋病诊断。大多数接受HAART治疗的HIV/HPV合并感染患者, HPV相关癌症如宫颈癌,但发生HPV相关口腔癌的风险较高。 癌症的风险被认为是由于作为HAART治疗的结果的更长的预期寿命。但目前还不清楚 为什么HAART治疗对HPV+ HNCSCC与HPV+宫颈癌可能有不同的效果。 我们的总体假设是HAART治疗影响HPV+ HNC的进展。这增加 患有持续性口腔HPV感染并进展为HNCSCC的PLHIV人数,预后较差, 与死我们建议集中在三个方面来检验这一假设。 具体目标1。高效抗逆转录病毒治疗诱导口腔上皮细胞HPV致癌倾向的差异分析 细胞具体目标2:研究HAART对致癌标志物和代谢途径的影响 与HPV+ HNSCC相关。具体目标3:研究HAART对糖酵解的影响, 线粒体呼吸
英文摘要
SUMMARY The overall incidence of HPV+ head and neck squamous cell carcinoma (HNSCC) has exhibited an increasing trend over the last few decades, and has now in the U.S. overtaken cervical cancer as the most common site of HPV related cancer. The majority of patients present with advanced-stage HNSCC are without a clinical history of pre-malignancy. Because there is a paucity of pre-cancer clinical samples the studying the steps of cancer progression that would provide an understanding of the carcinogenic we have developed an in vitro progression model. Interestingly, HPV+ patients compared to HPV negative (HPV-) patients have an improved overall prognosis and greater disease-free survival, attributed partly to a better response to radio- and/or chemotherapy. The mechanisms and natural history of oral HPV infection and carcinogenic progression are poorly understood. Men and women infected with human immunodeficiency virus (HIV) have higher rates of HPV16 infection, longer persistence of HPV16, increased incidence of HNSCC, poorer prognosis, as well as more recurrences after definitive therapy. There have been substantial changes in the burden of cancer affecting HIV-infected individuals in the U.S. during the period spanning the introduction of highly active anti- retroviral therapy (HAART). Scaling-up of HAART therapy has dramatically increased the life expectancy of people living with HIV (PLHIV). As a result of these temporal changes, non-AIDS-defining cancers have come to comprise the majority of cancers in HIV-infected persons during the HAART era. Among these emerging malignancies, HPV-associated cancers of the oral cavity/pharynx increased significantly following an AIDS diagnosis. Most patients with HIV/HPV co-infections on HAART therapy have reduced risk of developing HPV-associated cancers such as cervical cancer but have a higher risk of developing HPV-associated oral cancers the risk is suggested to be due to longer life expectancy as a results of HAART therapy. But it is unclear why HAART therapy may have different effects on HPV+ HNCSCC versus HPV+ cervical cancers. Our overarching hypothesis is that HAART therapy affects the progression of HPV+ HNC. This increases the numbers of PLHIV who have persistent oral HPV infections that progress to HNCSCC, poorer prognosis, and death. We propose to focus on three areas to test this hypothesis. Specific Aim 1. Analyze HAART induced differences of HPV carcinogenic propensity in oral epithelial cells. Specific Aim 2: Investigate the effect of HAART on carcinogenic markers and metabolic pathways associated with HPV+ HNSCC. Specific Aim 3: Study the effect of HAART on glycolysis versus mitochondrial respiration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the Role of HAART in the Progression of HPV-Associated Oral Cancer
Effect of HPV16 and ART on the Epigenome Leading to AIDS-Associated Oral Cancer
Effect of HPV16 and ART on the Epigenome Leading to AIDS-Associated Oral Cancer
Mechanistic Investigations of Ethnic Differences in HPV Variants
海外基金